The Canada-listed cannabis stocks we’ve weeded out have reported big revenue numbers relative to their market caps during the latest quarter
SmallCapPower | April 12, 2019: Big names in the cannabis industry have been leading the market, capturing majority of the space. However, under the radar, smaller players are beginning to gain market share and generate healthy revenue. The cannabis stocks we’ve discovered today have reported impressive revenues in relation to their market capitalization.
*Share prices as at April 10, 2019, data obtained from S&P Capital IQ
For Our Complete Coverage Of Canadian Marijuana Stocks Click Here
Trulieve Cannabis Corp. (CSE:TRUL) – $19.40
Cannabis
Trulieve is a seed-to-sale operation in the state of Florida, with plans to acquire additional facilities outside of Florida in 2019. The Company claims to be the largest fully licensed medical cannabis company in the State of Florida. Trulieve has expansion plans to add another 127,500 sq. ft., which the Company estimates will increase production by 10,215 kg. TRUL also has a network of 24 dispensaries selling branded products, with a total of 125 stock keeping units (SKUs) and over 137,000 unique patients. The Company plans to have 30 dispensaries by the end of Q1/19. On April 10, the Company announced Q4/18 results, reporting a revenue of US$35.9M, a 27% increase from Q3/18.
- Market Cap: $2.2 Billion
- 7-Day Total Return: -6.1%
- 30-Day Total Return: +21.6%
- Latest Quarter Revenue: US$35.9 Million (Q4/18)
Charlotte’s Web Holdings, Inc. (CSE:CWEB) – $28.54
Cannabis
Charlotte’s Web Holdings is a fully vertically integrated, CBD-focused company with operations based in Boulder, Colorado. The Company is the market leader in the production and distribution of hemp-derived cannabidiol (“CBD”) products. On January 15, 2019, the Company reported its 2018 harvested hemp results, stating a 10x increase in harvested hemp from the year prior. On March 28, the Company announced results for Q4/2018, reporting a 71% YoY increase in revenue to $21.5 million.
- Market Cap: $2.7 Billion
- 7-Day Total Return: -11.3%
- 30-Day Total Return: +21.6%
- Latest Quarter Revenue: $21.5 million (Q4/18)
Organigram Holdings Inc. (TSXV:OGI) – $9.24
Cannabis
Organigram Holdings is a Canada-based company that produces and sells cannabis oil and dried cannabis through its subsidiaries. Organigram is focused on indoor-grown cannabis for recreational and medical use in Canada. On February 26, OGI announced that it had signed a letter of intent (LOI) with the Société Québécoise du Cannabis (SQDC) to supply recreational cannabis in Quebec, making it one of three cannabis companies (TSX:WEED, TSX:APHA) to have supply deals in all 10 provinces. On January 28, the Company announced its Q1/19 financial results, reporting $12.4M in revenue, a 130% YoY increase.
- Market Cap: $1.4 Billion
- 7-Day Total Return: -6.6%
- 30-Day Total Return: +2.8%
- Latest Quarter Revenue: $12.4 Million (Q1/19)
MediPharm Labs Corp. (TSXV:LABS) – $4.75
Cannabis
MediPharm Labs operates a cGMP facility and ISO-9000-rated laboratory clean rooms in Barrie, Ontario. Due to its differentiated focused extracts-only business strategy, MediPharm acts as a strategic partner to any LP, providing both white-label production and contract processing. LABS is expanding globally and is currently developing an extraction facility in Australia, expected to be completed in H2/2019. The Company has signed multiple, multi-year extraction contracts, including agreements with prominent licensed producers (LPs) such as Canopy Growth, Supreme Cannabis, and Up Cannabis. On February 12, 2019, MediPharm announced that it had signed a $35M private label extraction agreement, with an option for an additional $13.5M with an undisclosed LP. On April 3, the Company released Q4/18 and year-end results, reporting revenue of $10.2M and a gross profit of $4.0M, making it one of the Top 10 cannabis companies in terms of revenue.
- Market Cap: $504.9 Million
- 7-Day Total Return: +31.2%
- 30-Day Total Return: +52.7%
- Latest Quarter Revenue: $10.2 Million (Q4/18)
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
